GREM1 and cancer: GREM1 (gremlin-1), a secreted BMP antagonist, promotes angiogenesis and pro-tumorigenic signaling pathways, and neutralizing antibody strategies have demonstrated efficacy in preclinical fibrosis and cancer models [36].